Transactions
NAMSA recapitalized by ArchiMed
Sep. 2020
Client: NAMSA pioneered the medical device CRO industry, with a 50+ year history serving premier medical device manufacturers from locations across the U.S., Europe, and East Asia
Role: Edgemont Partners acted as exclusive advisor to NAMSA in its majority recapitalization by ArchiMed
Location: Toledo, OH
Sector: Pharmaceutical Services
Lead Banker: David Blume
recapitalized by
